Globus Medical (GMED) Convertible Debt (2023)
Globus Medical's (GMED) quarterly Convertible Debt came in at $417.4 million in Q4 2023, up 1.87% quarter-over-quarter from $409.7 million in Q3 2023.
Powered by 
Analysis
Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends
Globus Medical (GMED) has reported Convertible Debt for 1 consecutive years, with $417.4 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Convertible Debt changed N/A year-over-year to $417.4 million; the trailing twelve-month figure through Dec 2023 stood at $417.4 million (changed N/A YoY), and the FY2023 full-year result was $417.4 million, changed N/A from the prior year.
- Convertible Debt grew to $417.4 million in Q4 2023 per GMED's latest filing, from $409.7 million in the prior quarter.
- Across five years, Convertible Debt topped out at $417.4 million in Q4 2023 and bottomed at $409.7 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Globus Medical | 9.98 Bn | 9.38 Bn | 548.17 Mn |